Table 1.
Correlations between ITGBL1 expression and clinicopathologic parameters in patients with GC
| Clinicopathological parameter | Total 231 |
Expression of ITGBL1 | p value | |
|---|---|---|---|---|
| Low (n=84, %) | High (n=147, %) | |||
| Age (years) | ||||
| < 60 | 100 | 38 (38.0) | 62 (62.0) | 0.680 |
| ≥ 60 | 131 | 46 (35.1) | 85 (64.9) | |
| Gender | ||||
| Male | 148 | 58 (39.2) | 90 (60.8) | 0.256 |
| Female | 83 | 26 (31.3) | 57 (68.7) | |
| Lauren type | ||||
| Intestinal type | 129 | 46 (35.7) | 83 (64.3) | 0.891 |
| Diffuse type | 102 | 38 (37.3) | 64 (62.7) | |
| Tumor size | ||||
| ≤ 5 cm | 127 | 53 (41.7) | 74 (58.3) | 0.074 |
| >5cm | 104 | 31 (29.8) | 73 (70.2) | |
| T classification | ||||
| T1, 2 | 84 | 37(44.0) | 47(56.0) | 0.239 |
| T3, 4 | 147 | 47 (32.0) | 100 (68.0) | |
| Lymph node metastasis | ||||
| Absent | 99 | 41 (41.4) | 58 (58.6) | 0.245 |
| Present | 132 | 43 (32.6) | 89 (67.4) | |
| TNM stage | ||||
| I | 63 | 29 (46.0) | 34 (54.0) | 0.030 |
| II | 55 | 18 (32.7) | 37 (67.3) | |
| III | 93 | 35 (37.6) | 58 (62.4) | |
| IV | 20 | 2 (10.0) | 18 (90.0) | |
| Early gastric cancer | ||||
| No | 183 | 58 (31.7) | 125 (68.3) | 0.007 |
| Yes | 48 | 26 (54.2) | 22 (45.8) | |
| Distant metastasis | ||||
| Absent | 211 | 82 (38.9) | 129 (61.1) | 0.013 |
| Present | 20 | 2 (10.0) | 18 (90.0) | |
aThe bold number represents the p-values with significant differences.
bP value was calculated by χ2 test or Fisher's exact test.